Oncternal Therapeutics (NASDAQ:ONCT) Upgraded to “Buy” at Brookline Capital Management
Brookline Capital Management upgraded shares of Oncternal Therapeutics (NASDAQ:ONCT – Free Report) from a hold rating to a buy rating in a report issued on...
Perdoceo Education’s (PRDO) Outperform Rating Reaffirmed at Barrington Research
Barrington Research reaffirmed their outperform rating on shares of Perdoceo Education (NASDAQ:PRDO – Free Report) in a report released on Monday, Benzinga reports. The firm...
Qualys (NASDAQ:QLYS) Rating Lowered to Hold at StockNews.com
StockNews.com cut shares of Qualys (NASDAQ:QLYS – Free Report) from a buy rating to a hold rating in a report published on Monday. Other equities...
Repligen (NASDAQ:RGEN) Stock Rating Lowered by Benchmark
Benchmark lowered shares of Repligen (NASDAQ:RGEN – Free Report) from a buy rating to a hold rating in a research note published on Monday morning,...
Pfizer (NYSE:PFE) Given “Buy” Rating at Truist Financial
Truist Financial reiterated their buy rating on shares of Pfizer (NYSE:PFE – Free Report) in a research note published on Monday morning, Benzinga reports. Truist...
Evercore ISI Increases Blue Owl Capital (NYSE:OWL) Price Target to $15.00
Blue Owl Capital (NYSE:OWL – Free Report) had its price target boosted by Evercore ISI from $14.00 to $15.00 in a research note released on...